TRxADE Health announced the appointment of Narasimhan Mani, Ph.D., MBA as Scienture’s President. Shankar Hariharan, Ph.D., the current President and CEO, will be CEO of Scienture. Rahul Surana, Ph.D., MBA has been promoted to Executive VP and COO of Scienture.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MEDS:
- TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC’s Executive Leadership Team
- Trxade Group’s Strategic Merger and Rebranding as Scienture Holdings
- Trxade Health acquires Scienture in all-stock transaction valued at $103M
- TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million
- Trxade Health announces special cash dividend of $1.50 per share